Clinical Trial Update: Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH [Phase 3]

View source ↗

Summary

Phase 3 bioequivalence study of Beclomethasone Dipropionate 40 mcg INH completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Asthma

Drugs mentioned

• Beclomethasone Dipropionate (beclomethasone dipropionate)

Snippet

Sponsor: Aurobindo Pharma Ltd | Conditions: Bronchial Asthma | Phase 3 | Status: COMPLETED | Results posted: 2020-11-13